FGF, Hareket Mekanizması, Parkinson Hastalığında Rol ve Terapötikler.
FGF, Mechanism of Action, Role in Parkinson's Disease, and Therapeutics.
DOI: 10.3389/fphar.2021.675725PMID: 34234672
FGF, Mechanism of Action, Role in Parkinson's Disease, and Therapeutics.
DOI: 10.3389/fphar.2021.675725PMID: 34234672
Recent advances in the pathology of prodromal non-motor symptoms olfactory deficit and depression in Parkinson's disease: clues to early diagnosis and effective treatment.
DOI: 10.1007/s12272-021-01337-3PMID: 34145553
Physiotherapy management of Parkinson's disease.
DOI: 10.1016/j.jphys.2021.06.004PMID: 34154949
Imagine that: cholinesterase inhibitor treatment of complex visual hallucinations of unknown aetiology.
DOI: 10.1080/13546805.2021.1941832PMID: 34142635
Body mass index variations in patients with Parkinson's disease treated with levodopa-carbidopa intestinal gel infusion: A case control study versus standard of care and subthalamic nucleus deep brain stimulation.
DOI: 10.1016/j.neurol.2020.11.017PMID: 34154827
MRI Guided Focused Ultrasound-Mediated Delivery of Therapeutic Cells to the Brain: A Review of the State-of-the-Art Methodology and Future Applications.
DOI: 10.3389/fneur.2021.669449PMID: 34220679
Locomotor activity and resting local field potential oscillatory rhythms of 6-OHDA mouse model of Parkinson's disease in response to acute and repeated treatments with L-dopa.
DOI: 10.1016/j.neulet.2021.136007PMID: 34098022
Multitarget therapeutic approaches for Alzheimer's and Parkinson's diseases: an opportunity or an illusion?
DOI: 10.4155/fmc-2021-0119PMID: 34137271
In silico study of levodopa in hydrated lipid bilayers at the atomistic level.
DOI: 10.1016/j.jmgm.2021.107972PMID: 34174554
Current Knowledge on the Background, Pathophysiology, and Treatment of Levodopa-Induced Dyskinesia – Literature Review.
DOI: 10.20944/preprints202106.0448.v1
LRRK2-NFATc2 Pathway Associated with Neuroinflammation May Be a Potential Therapeutic Target for Parkinson's Disease.
DOI: 10.2147/jir.s301531PMID: 34168481
Brain Disposition of Antibody-Based Therapeutics: Dogma, Approaches and Perspectives.
DOI: 10.3390/ijms22126442PMID: 34208575
Kayıtlar bilimsel kaynaklardan alınır. Bibliyografik kayıt sayısı, Türkçe çeviri veya editoryal onay sayısı değildir.